The U.S. Army is conducting market research on services to help the U.S. Army Chemical Materials Activity (CMA) to meet its assigned treaty and arms control missions under the Chemical Weapons Convention [Read more]
The man who fell ill after he was exposed to the nerve agent novichok in Amesbury has made a “small but significant improvement,” Salisbury District Hospital said in a statement on 10 [Read more]
Britain’s top counter-terrorism officer Sajid Javid on Wednesday confirmed two British citizens are critically ill after they were exposed to the Novichok nerve agent.1 Charlie Rowley, 45, and Dawn Sturgess, 44, collapsed [Read more]
An international Symposium on Medical Treatment of Chemical Warfare Victims was convened by the Organisation for the Prohibition of Chemical Weapons (OPCW) from 28 to 29 June in The Hague. More than [Read more]
New Chemical, Biological, Radiological and Nuclear (CBRN) collective protection tent system components were recently put to the test during an Air Force exercise at Joint Base Langley-Eustis, on June 20. During the [Read more]
Military Veterans may be eligible to receive medical care if they participated in U.S. Army chemical or biological substance testing from 1942 to 1975 and have an injury or disease that they [Read more]
The U.S. Army is conducting market research on partnering to accelerate the development of technologies that will enable personnel to assess, protect and mitigate chemical and biological threats. This Request for Information [Read more]
Following the October 2001 confirmation of anthrax in official government mail, a series of screening processes were implemented to safeguard the Pentagon and other Pentagon delegated facilities from biological hazards that might [Read more]
Team Aberdeen Proving Ground (APG) is hosting the APG Discovery Week Advanced Planning Briefing to Industry (APBI) on April 17-20, 2018, at APG, MD. The goal of the APG Discovery Week APBI [Read more]
In support of rapid development of safe and effective radiological/nuclear medical countermeasures for clinical use under emergency situations, the National Institute of Allergy and Infectious Diseases (NIAID) is seeking new or renewal [Read more]
© 2018 STEMAR MEDIA